A retrospective case-control study to assess and compare posaconazole/isavuconazole Ctrough in high-risk allogeneic hematopoietic cell transplant (HCT) recipients who may or may not received letermovir
Latest Information Update: 09 Apr 2021
At a glance
- Drugs Isavuconazonium (Primary) ; Isavuconazonium (Primary) ; Posaconazole (Primary) ; Posaconazole (Primary) ; Letermovir; Letermovir
- Indications Mycoses
- Focus Pharmacokinetics
- 09 Apr 2021 New trial record
- 29 Mar 2021 Results published in the Antimicrobial Agents and Chemotherapy